http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022101687-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cb227f1b2bab61a159af86433552d289
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-416
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-232
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2400-12
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6953
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-03
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L31-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L31-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-03
filingDate 2021-05-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_62c6bc29bd04ee2435e6e290007e7879
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_320ed4dbe33d089cbd832951352cabc3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ffa0f6748f4fb61ef3dbd6bf1de31f54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_460d75c38b364ba4f8810c0b95cde77c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3f97702f57ccc460ce6d65456cc713dd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_df6c8a8d3aaab42b149c4707771f11ee
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_19020a92165477eb1e9a6357fd7c7c97
publicationDate 2022-05-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2022101687-A1
titleOfInvention Nanofiber mesh comprising fucoidan, method and uses thereof
abstract The present disclosure relates to a nanofiber polymeric mesh immobilizing fucoidan, uses and method of production. The fucoidan-based polymeric substrate may be used as a skin patch for melanoma treatment, namely as an adjuvant after tumor resection.
priorityDate 2020-11-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009005867-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2706726-C1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID53864980
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7242
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226402551
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226405573
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16218417
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406078
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7083
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7813
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226482091
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226779028
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16402
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226493848

Total number of triples: 41.